Abstract
Primary hyperparathyroidism is a result of overproduction of parathyroid hormone by parathyroid adenoma. Surgical indication of primary hyperparathyroidism is well defined; however, nonspecific symptoms and their effect on quality of patients’ life are not considered on surgical decision-making. The aim of this study is to evaluate the effect of surgical therapy for primary hyperparathyroidism on general and swallowing related quality of life.
This cohort study was conducted prospectively between November 2018 and July 2020.
There were 145 patients with primary hyperparathyroidism included in data analysis. Patient operated for primary hyperparathyroidism were included in the study. General health–related and swallowing-related quality of life was evaluated before and after the surgery.
Improvement of general health–related quality of life was detected in 7 out of 8 domains of short form 36 questionnaire. Improvement of eating-related quality of life was detected in all domains of swallowing-related quality of life questionnaire.
Nonspecific or neuropsychiatric symptoms of PHPT should be evaluated before decision-making for the treatment and should be considered in surgical indications for PHPT.
Similar content being viewed by others
References
Perrier ND (2005) Asymptomatic hyperparathyroidism: a medical misnomer? Surg 137(2):127
Trombetti A, Christ ER, Henzen C (2016) Clinical presentation and management of patients with primary hyperparathyroidism of the Swiss Primary Hyperparathyroidism Cohort: a focus on neuro-behavioral and cognitive symptoms. J Endocrinol Invest 39(5):567
Lundgren E, Szabo E, Ljunghall S (1998) Population based case-control study of sick leave in postmenopausal women before diagnosis of hyperparathyroidism. BMJ 317(7162):848
Abboud B, Daher R, Boujaoude J (2011) Digestive manifestations of parathyroid disorders. World J Gastroenterol 17(36):4063–4066
Shah VN, Bhadada SK, Bhansali A (2014) Effect of gender, biochemical parameters & parathyroid surgery on gastrointestinal manifestations of symptomatic primary hyperparathyroidism. Indian J Med Res 139(2):279–284
Bilezikian JP, Brandi ML, Eastell R (2014) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab 99:3561–3569
Koçyiğit H, Aydemir Ö, Ölmez N, Memiş A (1999) Kısa Form-36 (KF-36)’nın Türkçe Versiyonunun Güvenilirliği ve Geçerliliği. İlaç ve Tedavi Dergisi 12:102–106
Demir N, Arslan SS, İnal Ö, Ünlüer NÖ, Karaduman AA (2016) Reliability and validity of the Turkish Version of the Swallow Quality of Life Questionnaire. Turk J Physither Rehabil 27:19–24
Sheldon DG, Lee FT, Neil NJ, Ryan JA Jr (2002) Surgical treatment of hyperparathyroidism improves health-related quality of life. Arch Surg 137:1022–1026
Adler JT, Sippel RS, Schaefer S, Chen H (2008) Preserving function and quality of life after thyroid and parathyroid surgery. Lancet Oncol 9:1069–1075
Tzikos G, Chorti A, Evangelos S (2021) Quality of life in patients with asymptomatic primary hyperparathyroidism after parathyroidectomy: a 3-year longitudinal study. Endocrine Practice 27:16–722
Caillard C, Sebag F, Mathonnet M (2017) Prospective evaluation of quality of life (SF-36v2) and nonspecific symptoms before and after cure of primary hyperparathyroidism (1-year follow-up). Surg 141:153–160
Leong KJ, Sam RC, Garnham AV (2010) Health-related quality of life improvement following surgical treatment of primary hyperparathyroidism in a United Kingdom population. Surg 8:5–8
Pinchot SN, Youngwirth L, Rajamanickam V, Schaefer S, Sippel R, Chen H (2012) Changes in swallowing-related quality of life after parathyroidectomy for hyperparathyroidism: a prospective cohort study. Oncologist 17(10):1271–1276
Bannani S, Christou N, Guérin C (2018) Effect of parathyroidectomy on quality of life and non-specific symptoms in normocalcaemic primary hyperparathyroidism. Br J Surg 105:223–229
Brito K, Edirimanne S, Eslick GD (2015) The extent of improvement of health-related quality of life as assessed by the SF-36 and Paseika scales after parathyroidectomy in patients with primary hyperparathyroidism – a systematic review and meta-analysis. Int J Surg 13:245–249
Author information
Authors and Affiliations
Contributions
• Study conception and design: BS, ND, ÖK, MH.
• Acquisition of data: BS, ND, AA.
• Analysis and interpretation of data: BS, MH.
• Drafting of manuscript: BS, MH.
• Critical revision of manuscript: BS, ÖK, MH.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This study was registered to clinicaltrials.gov with id: NCT03968510.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sevinç, B., Damburacı, N., Karahan, Ö. et al. Evaluation of Swallowing Related Quality of Life and Health Related Quality of Life in Patients with Primary Hyperparathyroidism. Indian J Surg (2022). https://doi.org/10.1007/s12262-022-03549-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12262-022-03549-3